Advertisement

European Journal of Epidemiology

, Volume 11, Issue 1, pp 107–117 | Cite as

Diphtheria: Changing patterns in the developing world and the industrialized world

  • Artur M. Galazka
  • Susan E. Robertson
Special Review

Abstract

In the past, diphtheria was considered one of the most serious childhood diseases because it took a heavy toll in health and life among preschool-aged children. Prior to the widespread availability of diphtheria toxoid, nearly 70% of cases were in children younger than 15 years of age. In the industrialized countries, immunization against diphtheria became widespread in the 1940s and 1950s. This led to a marked decrease in the incidence of diphtheria. There was also a decrease in circulating toxigenicCorynebacterium diphtheriae organisms, resulting in less natural boosting of antibody levels. This has led to gaps in the immunity of the adult population. Since 1990, diphtheria has made a spectacular comeback in several European countries, with a high proportion of cases in adults. In developing countries, immunization of infants with diphtheria toxoid was introduced within the Expanded Programme on Immunization in the late 1970s. Coverage rose slowly to 46% in 1985 and 79% in 1992. Because the pool of immunized persons is not yet large, the process of maintaining immunity still operates through natural mechanisms, including frequent skin infections caused byC. diphtheriae. But recently, several developing countries where coverage has been high for 5–10 years have reported diphtheria outbreaks. These outbreaks have been characterized by high case fatality rates, a large proportion of patients with complications, and their occurrence in both young and older age groups. In all countries, priority should be given to efforts to reach at least 90% coverage with three doses of diphtheria toxoid in children below one year of age. In countries where diphtheria has been successfully controlled, immunity levels should be maintained by booster doses.

Key words

Developing countries Diphtheria Diphtheria toxoid Diphtheria vaccination Immunization Industrialized countries Serology 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Galazka AM, Robertson SE, Oblapenko GP. Resurgence of diphtheria. Eur J Epidemiol 1995; 11: 95–105.Google Scholar
  2. 2.
    Baum KF, MacFarlane DE, Cupidore L, Serjeant GR.Corynebacterium diphtheriae in sickle cell leg ulcers in Jamaica. West Indian Med J 1985; 34: 24–28.Google Scholar
  3. 3.
    Bray JP, Burt EG, Potter EV, et al. Epidemic diphtheria and skin infections in Trinidad. J Infect Dis 1972; 126: 34–40.Google Scholar
  4. 4.
    Dauer CC. Trends in age distribution of diphtheria in the United States. Publ Health Rep 1950; 65: 1209–1218.Google Scholar
  5. 5.
    Fenakel E. Ein Beitrag zur Epidemiologie der Diptherie im zwanzigsten Jahrhundert. Basel: Karger, 1953.Google Scholar
  6. 6.
    Russel WT. The epidemiology of diphtheria during the last forty years. Medical Research Council, Special Report Series no. 247. London: HMSO, 1943.Google Scholar
  7. 7.
    Engelstein E. Diphtheria in Cracow in the last 50 years (in Polish). Cracow. Wyklady Chorob Zakaznych przy Uniwersytecie Jagiellonskim, 1934.Google Scholar
  8. 8.
    Hoogendoorn D. Over de diphtherie in Nederland: Epidemiologie en prophylaxe. Zwolle: Tijl, 1948.Google Scholar
  9. 9.
    Peter R. Infectious diseases: Notified cases by age-group absolute and per 100,000 population, 1932–1975. Office of the Chief Medical Officer of Health, Section of Infectious Diseases, Ministry of Health, Netherlands, 1976.Google Scholar
  10. 10.
    Vogelsang TM. Diphtheria antitoxin in the blood of the adult population in Bergen, Norway, just after a diphtheria epidemic. J Infect Dis 1949; 85: 17–24.Google Scholar
  11. 11.
    Ipsen J. Immunization of adults against diphtheria and tetanus. New Engl J Med 1954; 251: 459–466.Google Scholar
  12. 12.
    WHO, Expanded Programme on Immunization. Information system: Summary for the WHO European Region, April 1994. WHO document WHO/EPI/CEIS/ 93.1/ EUR. Geneva: World Health Organization, 1994.Google Scholar
  13. 13.
    Kalapothaki V, Sapounas T, Xirouchaki E, et al. Prevalence of diphtheria carriers in a population with disappearing clinical diphtheria. Infection 1984; 12: 387–389.Google Scholar
  14. 14.
    Mencarelli M, Zanchi A, Cellesi C, et al. Molecular epidemiology of nasopharyngeal corynebacteria in healthy adults from an area where diphtheria vaccination has been extensively practiced. Eur J Epidemiol 1992; 8: 560–567.Google Scholar
  15. 15.
    Naumann P, Krech T, Maximescu P, et al. Phagenlysotypie und Epidemiologie der Diphtherieerkrankungen 1975 bis 1984. Dtsch Med Wochenschr 1986; 111: 71–82.Google Scholar
  16. 16.
    Gruner E, Opravil M, Altwegg M, von Graevenitz A. NontoxigenicCorynebacterium diphtheriae isolated from intravenous drug users. Clin Infect Dis 1994; 18: 94–96.Google Scholar
  17. 17.
    Efstratiou A, Tiley SM, Sangrador A, et al. Invasive disease caused by multiple clones ofCorynebacterium diphtheriae. Clin Infect Dis 1993; 17: 136.Google Scholar
  18. 18.
    Halioua B, Patey O, Emond JP, et al. Emergence recente en France d'infections systematiques aCorynebacterium diphtheriae. Med Mal Infect 1992; 22, HS: 76–78.Google Scholar
  19. 19.
    Wilson APR, Efstratiou A, Weaver E, et al. Unusual non-toxigenicCorynebacterium diphtheriae in homosexual men. Lancet 1992; 339: 998.Google Scholar
  20. 20.
    Guard RW. Non-toxigenicCorynebacterium diphtheriae causing subacute bacterial endocarditis: Case report. Pathology 1979; 11: 533–535.Google Scholar
  21. 21.
    Tiley SM, Kociuba KR, Heron LG, Munro R. Infective endocarditis due to nontoxigenicCoryne-bacterium diphtheriae: Report of seven cases and review. Clin Infect Dis 1993; 16: 271–275.Google Scholar
  22. 22.
    Zuber PLF, Gruner E, Altwegg M, von Graevenitz A. Invasive infection with non-toxigenicCorynebacterium diphtheriae among drug users. Lancet 1992; 339: 1359.Google Scholar
  23. 23.
    Page MI. The present problem of diphtheria control in the United States. Am J Publ Health 1962; 52: 68–74.Google Scholar
  24. 24.
    US Center for Disease Control. Diphtheria surveillance: Summary 1971–1975. Report no. 12. Atlanta: US Public Health Service, 1978.Google Scholar
  25. 25.
    Chen RT, Broome CV, Weinstein RA, et al. Diphtheria in the United States, 1971–81. Am J Publ Health, 1985; 75: 1393–1397.Google Scholar
  26. 26.
    Basappa K. Epidemiological study of diphtheria in retrospect. J Indian Med Assoc 1963; 41: 397–400.Google Scholar
  27. 27.
    Bhargava HS, Bhatt AN. A study of 275 cases of diphtheria. J Indian Med Assoc 1960; 35: 243–248.Google Scholar
  28. 28.
    Chintu C, Bathirunathan N, Patel JM. Diphtheria at the University Teaching Hospital, Lusaka. East Afr Med J 1978; 55: 36–38.Google Scholar
  29. 29.
    Garg BK, Sharma BK. Diphtheria in Kanpur. Indian Pediatr 1964; 1: 436–444.Google Scholar
  30. 30.
    Khuri-Bulos N. Diphtheria in Jordan: A diminishing yet important paediatric disease. J Trop Med Hyg 1980; 83: 79–83.Google Scholar
  31. 31.
    Singh M, Saidali A, Bakhtiar A, Arya LS. Diphtheria in Afganistan: A review of 155 cases. J Trop Med Hyg, 1985; 88: 373–376.Google Scholar
  32. 32.
    Tibrewala NS, Potdar RD, Talathi SB, et al. Age profile of diphtheria in Bombay: A study of 3453 recent cases in children. Progr Drug Res 1975; 19: 412–422.Google Scholar
  33. 33.
    Kim-Farley R, Soewarso TI, Karyadi A, Adhyatma M. Assessing the impact of the Expanded Programme on Immunization: the example of Indonesia. Bull WHO 1987; 63: 203–206.Google Scholar
  34. 34.
    Jones EE, Kim-Farley RJ, Algunaid M, et al. Diphtheria: a possible foodborne outbreak in Hodeia, Yemen Arab Republic. Bull WHO 1985; 63: 286–293.Google Scholar
  35. 35.
    Khuri-Bulos N, Hamzah Y, Sammerrai SM, et al. The changing epidemiology of diphtheria in Jordan. Bull WHO 1988; 66: 65–68.Google Scholar
  36. 36.
    Loevinsohn BP. The changing age structure of diphtheria patients: evidence for the effectiveness of EPI in the Sudan. Bull WHO 1990; 68: 353–357.Google Scholar
  37. 37.
    Van Geldermalsen AA, Wenning U. A diphtheria epidemic in Lesotho, 1989: Did vaccination increase the population susceptibility? Ann Trop Paediatr 1993; 13: 13–20.Google Scholar
  38. 38.
    Youwang Y, Jianming D, Yong X, Pong Z. Epidemiological features of an outbreak of diphtheria and its control with diphtheria toxoid immunization. Int J Epidemiol 1992; 21: 807–811.Google Scholar
  39. 39.
    Dif A, Grangaud JP, Djender L, Mesbach S. A propos des problèmes posés par l'epidemie de diphterie en Algerie en 1993. J. Alg Med 1994; 4: 177–180.Google Scholar
  40. 40.
    Galazka A. Diphtheria: The Immunological Basis for Immunization. WHO document WHO/EPI/GEN/ 93.12. Geneva: World Health Organization, 1993.Google Scholar
  41. 41.
    Groer F, Kassowitz K. Studien über die normale Diphtherie: Immunität des Menschen. Z Immun Forsch Exp Teil Orig 1915; 23: 108–126.Google Scholar
  42. 42.
    Zingher A. The Schick test performed on more than 150,000 children in public and parochial schools in New York (Manhattan and the Bronx). Am J Dis Child 1923; 25: 392–405.Google Scholar
  43. 43.
    Chakraborty SM, Choudhuri AB. Isolation of toxigenic strains ofC. diphtheriae from skin lesions of children in a rural West Bengal community. Indian J Med Res 1969; 57: 1651–1658.Google Scholar
  44. 44.
    Chason OL. Diphtheria immunity in rural Alabama. Am J Hyg 1936; 23: 539–557.Google Scholar
  45. 45.
    Daniel E, Galazka A, Krajewski J, Kukiz T. The assessment of the potency of diphtheria toxoid on the basis of the Jensen test (in Polish). Medyk i Medycyna, 1957; 2: 5–12.Google Scholar
  46. 46.
    Fan PL. Control of diphtheria, Part I: Schick test among Chinese. Chin Med J 1937; 51: 879–892.Google Scholar
  47. 47.
    Gomez L, Navarro R, Kapauan AM. The Schick reaction in Filipinos. Philipp J Sci 1922; 20: 323–330.Google Scholar
  48. 48.
    Gunatillake PDP, Taylor G. The role of cutaneous diphtheria in the acquisition of immunity. J Clin Microbiol 1981; 66: 83–88.Google Scholar
  49. 49.
    Jezek Z, Rusinko M, Hejdova E, et al. Schick testing survey in Mongolian People's Republic. J Hyg Epidemiol Microbial Immunol 1972; 16: 129–140.Google Scholar
  50. 50.
    Miyamura K, Murata R, Kono R. Status of antitoxic immunity against diphtheria in Japan. Jap J Med Sci Biol 1983; 326: 177–190.Google Scholar
  51. 51.
    Muyembe JJ, Gatti F, Spaepen J, Vandepitte J. L'epidemiologie de la diphterie en Republique du Zaire: Le rôle de l'infection cutanée. Ann Soc Belg Med Trop 1972; 2: 141–152.Google Scholar
  52. 52.
    Stransky E, Felix NS. Susceptability of Filipino children to diphtheria. J Philipp Med Assoc 1949; 25: 491–495.Google Scholar
  53. 53.
    Allerdist H, Ehrengut W, Fofana Y. Diphtheria immunity in Mali: Mothers and their neonates and children under two years of age. Trop Med Parasit 1981; 32: 274–275.Google Scholar
  54. 54.
    Liebow AA. Diphtheria and the Schick test in the tropics. Intern Arch Allergy 1958; 12: 42–58.Google Scholar
  55. 55.
    Ayyagari A, Venugopalan A, Ray SN. Studies on diphtheria infection in and around Delhi: A Bacteriological study from faucial and cutaneous lesions. J Indian Med Assoc 1975; 65: 328–331.Google Scholar
  56. 56.
    Chhabra HL, Sharma RG, Chugh TD, et al.Corynebacterium diphtheriae in surgical wounds. Indian J Med Res 1981; 179–180.Google Scholar
  57. 57.
    Rahman KM, Khan HM, Haq JA. Incidence of cutaneous diphtheria in Bangladesh. Bangl Med Res Counc Bull 1983; 9: 49–53.Google Scholar
  58. 58.
    Bezjak V, Farsey SJ.Corynebacterium diphtheriae in skin lesions in Ugandan children. Bull WHO 1970; 43: 643–650.Google Scholar
  59. 59.
    Mhalu FS, Lindqvist KG.Corynebacterium diphtheriae infections in Tanzania. East Afr Med J 1974; 51: 44–50.Google Scholar
  60. 60.
    Marples MJ, Bacon DF. Some observations on the distribution ofCorynebacterium diphtheriae in Western Samoa. Trans Roy Soc Trop Med Hyg 1956; 50: 72–76.Google Scholar
  61. 61.
    Cellesi C, Zanchi A, Michelangeli C, et al. Immunity to diphtheria in a sample of adult population from central Italy. Vaccine, 1989; 7: 417–420.Google Scholar
  62. 62.
    Dadswell JV, Rowlands DF, Sheffield FW, et al. Susceptibility to diphtheria. Lancet 1978 (i): 428–430.Google Scholar
  63. 63.
    Dalmatov VV, Gotvald RN, Tumorina SZ, et al. Serological surveillance of diphtheria infection (in Russian). J Microbiol Epidemiol Immunol 1986; 12: 43–47.Google Scholar
  64. 64.
    Maksimova NM, Sukhorukova NL, Egorkov NA, et al. State of immunity to diphtheria and tetanus in some administrative regions of the RSFSR (in Russian). J Microbiol Epidemiol Immunol 1984; 4: 58–63.Google Scholar
  65. 65.
    Forsell P. Diphtheria immunity in Victoria. Med J Aust 1972; 1: 1023–1026.Google Scholar
  66. 66.
    Kerttula Y, Nors T, Kuronen T, Turpeinen T. Immunity to diphtheria in Helsinki in 1975. Scand J Infect Dis 1980; 12: 37–39.Google Scholar
  67. 67.
    Miyamura K, Nishio S, Ito A, et al. Micro cell culture method for determination of diphtheria toxin and antitoxin using VERO cells, I: Studies on factors affecting the toxin and antitoxin titration. J. Biol Stand 1974; 2: 189–201.Google Scholar
  68. 68.
    Thilo W, Farchmin F, Holzer E, et al. Serologische Immunitat gegen Diphtherie 1986. Z Klin Med 1987; 42: 1807–1808.Google Scholar
  69. 69.
    Naumann P, Hagedorn H-J, Paatz R. Diphtherie Immunitat und ihre epidemiologische Bedeutung. Dtsch Med Wochenschr 1983; 108: 1090–1096.Google Scholar
  70. 70.
    Schwartz SA, Bukova VE, Pichushkov AV. Time course of diphtheria morbidity and population immunity (in Russian). J Microbiol Epidemiol Immunol 1987; 2: 26–32.Google Scholar
  71. 71.
    Galazka A, Kardymowicz B. Immunity against diphtheria in adults in Poland. Epidemiol Infect 1989; 103: 587–593.Google Scholar
  72. 72.
    Kjeldsen K, Simonsen O, Heron I. Immunity against diphtheria and tetanus in the age group 30–70 years. Scand J Infect Dis 1988; 20: 177–185.Google Scholar
  73. 73.
    Christenson B, Bottiger M. Serological immunity to diphtheria in Sweden in 1978 and 1984. Scand J Infect Dis 1986; 18: 227–233.Google Scholar
  74. 74.
    Sargent RK, Rossing TH, Dowton SB, et al. Diphtheria immunity in Massachusetts: A study of three urban patient populations. Am J Med Sci 1984; 287: 37–39.Google Scholar
  75. 75.
    WHO Expanded Programme on Immunization. Diphtheria and measles control, China. Wkly Epidemiol Rec 1988; 63: 225–227.Google Scholar
  76. 76.
    Anusz Z, Abgarowicz A. Levels of diphtheria and tetanus antibodies in children aged 0–14 years determined by the passive hemagglutination test (in Polish). Przegl Epidemiol 1973; 27: 109–118.Google Scholar
  77. 77.
    Simonsen O. Vaccination against tetanus and diphtheria: Evaluation of immunity in the Danish population, guidelines for revaccination, and the methods for control of vaccination programs. Dan Med Bull 1989; 36: 24–47.Google Scholar
  78. 78.
    Cohen P, Schneck H, Dubow E, Cohlan SQ. The changed status of diphtheria immunity. Pediatrics 1949; 3: 630–637.Google Scholar
  79. 79.
    Crossley K, Irvine P, Warren JB, et al. Tetanus and diphtheria immunity in urban Minnesota adults. JAMA, 1979; 232: 2298–2300.Google Scholar
  80. 80.
    WHO Expanded Programme on Immunization. Diphtheria epidemic, Ukraine. Wkly Epidemiol Rec 1994; 69: 253–258.Google Scholar

Copyright information

© Kluwer Academic Publishers 1995

Authors and Affiliations

  • Artur M. Galazka
    • 1
  • Susan E. Robertson
    • 1
  1. 1.Global Programme for Vaccines and ImmunizationWorld Health OrganizationGeneva 27Switzerland

Personalised recommendations